本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Esperion Therapeutics Inc.

2.63
-0.1100-4.01%
盤前2.660.0300+1.14%07:24 EDT
成交量:635.27萬
成交額:1,670.32萬
市值:6.75億
市盈率:-24.10
高:2.86
開:2.74
低:2.54
收:2.74
52周最高:4.18
52周最低:0.6925
股本:2.57億
流通股本:2.37億
量比:1.64
換手率:2.68%
股息:- -
股息率:- -
每股收益(TTM):-0.1091
每股收益(LYR):-0.1091
淨資產收益率:97.76%
總資產收益率:9.30%
市淨率:-2.24
市盈率(LYR):-24.10

資料載入中...

2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/25

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/25

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/22

重要事件披露

Form 8-K - Current report
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/18

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/11

重要事件披露

Form 8-K - Current report
2024/01/03

重要事件披露

Form 8-K - Current report
2023/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07

重要事件披露

Form 8-K - Current report
2023/10/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/30

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/28

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/24

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities